INTRAGASTRIC BALLOON

Course overview

WITH OVER 1.4 BILLION ADULTS WORLDWIDE CATEGORIZED AS OVERWEIGHT OR OBESE AND AN INCREASE IN OBESITY-RELATED HEALTH CONDITIONS, A NEED FOR EFFECTIVE TREATMENT AND MANAGEMENT MODALITIES IS CRUCIAL. INTRAGASTRIC BALLOONS SERVE AS A MINIMALLY INVASIVE TOOL TO COMBAT THE OBESITY PANDEMIC. THERE ARE MULTIPLE INTRAGASTRIC BALLOONS APPROVED FOR THE UNITED STATES AND EUROPEAN MARKETS. INDICATIONS IN THE USA INCLUDE A BMI OF 30 TO 35 KG/M^2 BUT A BMI OF 27 TO 35 KG/M^2 IN EUROPE. THIS ACTIVITY REVIEWS THE INDICATIONS, CONTRAINDICATIONS, AND PATHOPHYSIOLOGY OF INTRAGASTRIC BALLOONS AND HIGHLIGHTS THE ROLE OF THE INTERPROFESSIONAL TEAM IN EVALUATING AND TREATING THIS CONDITION.